SCHEMBL2402485

SCHEMBL2402485

CC(c1ccccc1)c1cc(C(N)=O)c2ccccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA1 Q15788 1/20 0.55
NCOA3 Q9Y6Q9 1/20 0.55
TACR3 P29371 5/20 0.45
DHODH Q02127 1/20 0.45
GRM2 Q14416 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
IKBKB O14920 1/20 0.41
AURKA O14965 2/20 0.41
RPS6KB1 P23443 2/20 0.41
AURKB Q96GD4 1/20 0.41
KDM4E B2RXH2 2/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30647460 0.85 NCOA1 (0.57) NCOA1NCOA3TACR3DHODHGRM2
SCHEMBL30647462 0.85 NCOA1 (0.46) NCOA1NCOA3TACR3DHODHGRM2
SCHEMBL4563284 0.83 NCOA1 (0.52) NCOA1NCOA3TACR3DHODHGRM2
SCHEMBL2511408 0.83 PARP1 (0.43) NCOA1NCOA3SMN1; SMN2IKBKBAURKA
SCHEMBL30647505 0.82 NCOA1 (0.53) NCOA1NCOA3TACR3DHODHGRM2
SCHEMBL30647468 0.81 NCOA1 (0.43) NCOA1NCOA3TACR3DHODHGRM2
SCHEMBL30647497 0.81 NCOA1 (0.47) NCOA1NCOA3GRM2TSHRSMN1; SMN2
SCHEMBL30647456 0.81 NCOA1 (0.47) NCOA1NCOA3DHODHGRM2TSHR
SCHEMBL2462376 0.80 NCOA1 (0.54) NCOA1NCOA3TACR3GRM2SMN1; SMN2
SCHEMBL2402873 0.80 NCOA1 (0.54) NCOA1NCOA3TACR3GRM2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011119693-A1 TRPV4 ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2011-09-29 WO disclosed